Evidence map›Paper›PMID 39509449›Full record

ArticlePloS one2024

Sarcopenia and frailty among older Chinese adults: Findings from the CHARLS study.

Weiwei Xu, Jiasheng Cai, Yichen Liu, Lian Li, Xiaomei Ye, Ping Wang, Jiaping Lu, Mohammed Ahmed Al-Kaif, Min Zhang

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Digital health technology burden and frustration among patients with multimorbidity.Journal of the American Medical Informatics Association : JAMIA · 2026
    Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Weiwei XuDepartment of Endocrinology and Metabolism, Qingpu Branch of Zhong Shan Hospital Affiliated to Fudan University, Shanghai, China.
Jiasheng CaiDepartment of Cardiology, Qingpu Branch of Zhong Shan Hospital Affiliated to Fudan University, Shanghai, China.
Yichen LiuDepartment of Endocrinology and Metabolism, Qingpu Branch of Zhong Shan Hospital Affiliated to Fudan University, Shanghai, China.
Lian LiDepartment of Endocrinology and Metabolism, Qingpu Branch of Zhong Shan Hospital Affiliated to Fudan University, Shanghai, China.
Xiaomei YeDepartment of Endocrinology and Metabolism, Qingpu Branch of Zhong Shan Hospital Affiliated to Fudan University, Shanghai, China.
Ping WangDepartment of Endocrinology and Metabolism, Qingpu Branch of Zhong Shan Hospital Affiliated to Fudan University, Shanghai, China.
Jiaping LuDepartment of Endocrinology and Metabolism, Qingpu Branch of Zhong Shan Hospital Affiliated to Fudan University, Shanghai, China.
Mohammed Ahmed Al-KaifDepartment of Cardiology, Qingpu Branch of Zhong Shan Hospital Affiliated to Fudan University, Shanghai, China.
Min ZhangDepartment of Endocrinology and Metabolism, Qingpu Branch of Zhong Shan Hospital Affiliated to Fudan University, Shanghai, China.ORCID 0009-0004-4883-8379

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSarcopenia and frailty are common among elderly individuals and present substantial health hazards. Exploring their relationship is essential for optimizing geriatric healthcare, particularly within the context of China.

methodsA population-based cross-sectional design was employed using data from the China Health and Retirement Longitudinal Study (CHARLS). The study enrolled 5,714 participants aged ≥60 years who underwent assessment for sarcopenia following the criteria established by the Asia Working Group for Sarcopenia (AWGS 2019) in 2019. Frailty status was determined using a frailty index that categorized participants into robustness, pre-frailty, and frailty stages. Multivariable logistic regression models were employed to examine the relationship between sarcopenia and frailty and pre-frailty conditions. Subgroup and interaction analyses were performed to explore the robustness of the associations between sarcopenia and frailty across different subgroups.

resultsAmong the participants, 1,028 (18.0%) were identified as frailty, 2,987 (52.3%) as pre-frailty, and 645 (11.3%) had sarcopenia. Sarcopenia demonstrated an independent association with higher risks of frailty (OR = 2.13, 95% CI: 1.52-2.99) and pre-frailty (OR = 1.42, 95% CI: 1.20-1.81) in the multivariable logistic analysis. Subgroup and interaction analyses consistently demonstrated significant associations across nearly all demographic and health-related subgroups.

conclusionsThis study highlights that sarcopenia is significantly and independently associated with frailty and pre-frailty among older adults in China. Early detection and targeted interventions for sarcopenia are crucial to mitigate frailty and its adverse health outcomes in aging populations, emphasizing the need for tailored healthcare strategies to promote healthy aging.

Indexed as

Frail ElderlyFrailtySarcopeniaAgedAged, 80 and overChinaCross-Sectional StudiesEast Asian PeopleFemaleGeriatric AssessmentHumansLogistic ModelsLongitudinal StudiesMaleMiddle Aged

Identifiers

PMID39509449
PMCPMC11542859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.